Cargando…

Paraneoplastic recurrent tumefactive demyelination in a 62-year-old man with metastatic seminoma

Detalles Bibliográficos
Autores principales:	Thebault, Simon, Hanes, Ilana, Woulfe, John, Bourque, Pierre R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2018
Materias:	Clinical/Scientific Notes
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6299676/ https://www.ncbi.nlm.nih.gov/pubmed/30588483 http://dx.doi.org/10.1212/NXI.0000000000000527

Ejemplares similares

Case Report: Paraneoplastic Tumefactive Demyelination Associated With Seminoma
por: Shiraishi, Wataru, et al.
Publicado: (2022)

Tumefactive demyelination in a patient with relapsing-remitting MS on ocrelizumab
por: Moreira Ferreira, Vanessa F., et al.
Publicado: (2019)

Tumefactive demyelination with a transient appearance of oligoclonal bands in MS under fingolimod
por: Okada, Kazumasa, et al.
Publicado: (2018)

Recurrent tumefactive demyelination: An unusual presentation
por: Bhargava, Amita, et al.
Publicado: (2015)

Recurrent tumefactive demyelinating lesions in an elderly woman
por: Weil, Erika L., et al.
Publicado: (2022)

Paraneoplastic Dermatomyositis Associated with Metastatic Seminoma
por: Yoshie, Hidekazu, et al.
Publicado: (2016)

Tumefactive inflammatory lesions in juvenile metachromatic leukodystrophy
por: Meier, Kolja, et al.
Publicado: (2020)

A Case of Relapsing-Remitting Tumefactive Demyelination
por: Wadhwa, Ankur, et al.
Publicado: (2019)

Isolated Medullary Tumefactive Demyelination Masquerading as Tumor
por: Manoj,, et al.
Publicado: (2022)

Tumefactive brain lesion with rapid cavity formation associated with anti-aquaporin-4 antibody
por: Uehara, Takuya, et al.
Publicado: (2016)

Tumefactive demyelinating disease with isolated spinal cord involvement
por: Makary, Mina S, et al.
Publicado: (2014)

Silent Tumefactive Demyelinating Lesions and Radiologically Isolated Syndrome
por: Ekmekci, Ozgul, et al.
Publicado: (2018)

Tumefactive demyelination: Clinical outcomes, lesion evolution and treatments
por: Brod, Staley A, et al.
Publicado: (2019)

Tumefactive demyelinating CNS lesion in a 60-year-old woman with familial Mediterranean fever
por: Trostel, Constanze, et al.
Publicado: (2021)

Tumefactive demyelination following herbal supplement use: Cause or coincidence?
por: Dubey, D, et al.
Publicado: (2016)

Progression of tumefactive demyelinating lesion in a child demonstrated with MRI
por: De Simone, Marta, et al.
Publicado: (2017)

AZD-1222: Tumefactive demyelinating brain lesion : case report
Publicado: (2022)

Tumefactive Demyelination—A Rare Presentation of Anti-MOG Syndrome
por: Sivadasan, Sesh, et al.
Publicado: (2022)

Metastatic “Burned Out” Seminoma Causing Neurological Paraneoplastic Syndrome—Not Quite “Burned Out”
por: Freifeld, Yuval, et al.
Publicado: (2018)

Paraneoplastic cerebellar ataxia with central hypoventilation
por: Kunchok, Amy, et al.
Publicado: (2016)

Recurrent Fulminant Tumefactive Demyelination With Marburg-Like Features and Atypical Presentation: Therapeutic Dilemmas and Review of Literature
por: Vakrakou, Aigli G., et al.
Publicado: (2020)

Pitfalls in the diagnosis of a tumefactive demyelinating lesion: A case report
por: Gavra, Maria, et al.
Publicado: (2011)

Neuroimaging features of tumefactive demyelinating lesions: A rare case report
por: Febyan, et al.
Publicado: (2020)

Immunopathology of Tumefactive Demyelinating Lesions-From Idiopathic to Drug-Related Cases
por: Vakrakou, Aigli G., et al.
Publicado: (2022)

Clinical spectrum and prognosis of pathologically confirmed atypical tumefactive demyelinating lesions
por: Zhang, Yajing, et al.
Publicado: (2023)

Amphiphysin-positive paraneoplastic myelitis and stiff-person syndrome
por: Faissner, Simon, et al.
Publicado: (2016)

Chinese Guidelines for the Diagnosis and Management of Tumefactive Demyelinating Lesions of Central Nervous System
Publicado: (2017)

Tumefactive Demyelination Associated with Bilateral Optic Neuritis in Neuromyelitis Optica Spectrum Disorders
por: Verma, Rajesh, et al.
Publicado: (2019)

Tumefactive demyelination after covid-19 successfully treated with betainterferon 1A
por: Araújo, Victor Oliveira, et al.
Publicado: (2022)

Defining the natural history of tumefactive demyelination: A retrospective cohort of 257 patients
por: Fereidan‐Esfahani, Mahboubeh, et al.
Publicado: (2023)

Paraneoplastic cerebellar degeneration associated with noncutaneous Merkel cell carcinoma
por: Zhang, Cen, et al.
Publicado: (2014)

Paraneoplastic cerebellar degeneration associated with anti-ITPR1 antibodies
por: Berzero, Giulia, et al.
Publicado: (2017)

Autopsy-proven demyelination associated with infliximab treatment
por: Bradshaw, Michael J., et al.
Publicado: (2016)

Negative commercial screening test for paraneoplastic antibodies in a case of opsoclonus
por: Vandenbussche, Nicolas, et al.
Publicado: (2017)

Pruritic rash in a man with seminoma
por: Siller, Alfredo, et al.
Publicado: (2020)

A rare presentation of atypical demyelination: tumefactive multiple sclerosis causing Gerstmann’s syndrome
por: Gnanapavan, Sharmilee, et al.
Publicado: (2014)

Corrigendum: Chinese Guidelines for the Diagnosis and Management of Tumefactive Demyelinating Lesions of Central Nervous System
Publicado: (2017)

When tumefactive demyelination is truly a tumor: case report of a radiographic misdiagnosis
por: Taylor, Breanna, et al.
Publicado: (2021)

Myelodysplastic syndrome with progressive multifocal predominantly pontine demyelination
por: Bhattacharyya, Shamik, et al.
Publicado: (2015)

MOG antibodies in combined central and peripheral demyelination syndromes
por: Vazquez Do Campo, Rocio, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_kl06squh9jjn80sg6g5tv0782a